Key result
In elderly patients with heart failure, CRT-D was associated with similar survival compared to CRT-P in a propensity score-matched cohort.
Why the study?
Does cardiac resynchronization therapy with a defibrillator (CRT-D) reduce mortality and cardiac hospitalisation compared to CRT without a defibrillator (CRT-P) in elderly patients with heart failure?
Cohort (n=170)
No
Does cardiac resynchronization therapy with a defibrillator (CRT-D) reduce mortality and cardiac hospitalisation compared to CRT without a defibrillator (CRT-P) in elderly patients with heart failure?
In elderly patients (≥75 years) with heart failure, CRT-D does not appear to offer a significant survival or hospitalization benefit over CRT-P.
Answers are grounded in this paper and cite their sources.
No survival difference supports cautious CRT-D selection in elderly HF; leaves open need for randomized confirmation.
Background Evidence regarding the incremental benefit of cardiac resynchronization therapy (CRT) with a defibrillator (CRT‐D) versus without (CRT‐P) in elderly patients with heart failure is limited. We compared mortality and cardiac hospitalisation between CRT‐D and CRT‐P in the elderly. Methods A retrospective chart review identified all consecutive patients with age ≥75 with CRT implantation over the last 10 years at a Canadian tertiary care cardiac centre. Kaplan‐Meier survival analyses and cumulative incidence curves were used to compare mortality and time to first cardiac hospitalisation, respectively, with CRT‐D versus CRT‐P over a 3 year period. Analyses were also repeated with propensity score matching based on age, sex, primary versus secondary prevention, date of implant, and Charlson Comorbidity Index. Results One hundred and seventy CRT patients were identified. A total of 128 received CRT‐D while 42 received CRT‐P. Median age was 79 (IQR 77‐81), and the majority were male (83%). CRT‐P patients had a higher burden of comorbidities (Charlson score 7, IQR 6‐8) than CRT‐D patients (Charlson score 5, IQR 5‐7; P < 0.001). There was no significant difference in survival between the two groups in an unmatched comparison (P = 0.69) and with a propensity score‐matched cohort (P = 0.91). Secondary prevention CRT‐D patients had a higher risk of hospitalisation compared to primary prevention CRT‐D patients; however, there was no significant difference in hospitalisation between the CRT‐D and CRT‐P groups. Conclusion This study suggests there is no significant difference in mortality or cardiac hospitalisation between CRT‐D and CRT‐P in elderly patients with heart failure.
No takes yet. Share an insight, caveat, or question.
Christie et al. (2018) conducted a cohort in heart failure (n=170). Cardiac resynchronization therapy with a defibrillator (CRT-D) vs. Cardiac resynchronization therapy without a defibrillator (CRT-P) was evaluated on Mortality and time to first cardiac hospitalisation (p=0.91). In elderly patients with heart failure, CRT-D was associated with similar survival compared to CRT-P in a propensity score-matched cohort.
Synapse has enriched 10 related papers. Consider them for comparative context: